445 related articles for article (PubMed ID: 18838228)
1. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia.
Konarzewska B; Wołczyński S; Szulc A; Galińska B; Popławska R; Waszkiewicz N
Psychoneuroendocrinology; 2009 Jan; 34(1):129-39. PubMed ID: 18838228
[TBL] [Abstract][Full Text] [Related]
2. Association between serum testosterone levels, body mass index (BMI) and insulin in male patients with schizophrenia treated with atypical antipsychotics--olanzapine or risperidone.
Konarzewska B; Galińska-Skok B; Waszkiewicz N; Łazarczyk-Kirejczyk J; Malus A; Simonienko K; Szulc A
Neuro Endocrinol Lett; 2014; 35(1):50-7. PubMed ID: 24625910
[TBL] [Abstract][Full Text] [Related]
3. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.
Kinon BJ; Ahl J; Liu-Seifert H; Maguire GA
Psychoneuroendocrinology; 2006 Jun; 31(5):577-88. PubMed ID: 16488084
[TBL] [Abstract][Full Text] [Related]
4. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU
J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
[TBL] [Abstract][Full Text] [Related]
5. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA
J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665
[TBL] [Abstract][Full Text] [Related]
6. Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.
Konarzewska B; Waszkiewicz N; Galińska B; Szulc A
Neuro Endocrinol Lett; 2013; 34(4):322-8. PubMed ID: 23803867
[TBL] [Abstract][Full Text] [Related]
7. [Prolactin secretion disturbances in schizophrenic patients treated with 2nd generation antipsychotics--risperidone and olanzapine].
Wyszogrodzka-Kucharska A; Kunert-Radek J; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(6):1143-55. PubMed ID: 16526181
[TBL] [Abstract][Full Text] [Related]
8. Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone.
van Bruggen M; van Amelsvoort T; Wouters L; Dingemans P; de Haan L; Linszen D
Psychoneuroendocrinology; 2009 Aug; 34(7):989-95. PubMed ID: 19264412
[TBL] [Abstract][Full Text] [Related]
9. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ
Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
[TBL] [Abstract][Full Text] [Related]
10. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients.
Melkersson K
J Clin Psychiatry; 2005 Jun; 66(6):761-7. PubMed ID: 15960571
[TBL] [Abstract][Full Text] [Related]
11. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.
Jeong HG; Lee MS; Lee HY; Ko YH; Han C; Joe SH
Int Clin Psychopharmacol; 2012 Jul; 27(4):177-83. PubMed ID: 22407277
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.
Canuso CM; Goldstein JM; Wojcik J; Dawson R; Brandman D; Klibanski A; Schildkraut JJ; Green AI
Psychiatry Res; 2002 Aug; 111(1):11-20. PubMed ID: 12140115
[TBL] [Abstract][Full Text] [Related]
13. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine.
Nakonezny PA; Byerly MJ; Rush AJ
J Sex Marital Ther; 2007; 33(3):203-16. PubMed ID: 17454518
[TBL] [Abstract][Full Text] [Related]
14. Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels.
Ahl J; Kinon BJ; Liu-Seifert H
Ann N Y Acad Sci; 2004 Dec; 1032():289-90. PubMed ID: 15677431
[TBL] [Abstract][Full Text] [Related]
15. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.
Volavka J; Czobor P; Cooper TB; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA
J Clin Psychiatry; 2004 Jan; 65(1):57-61. PubMed ID: 14744169
[TBL] [Abstract][Full Text] [Related]
16. Hyperprolactinemia and male sexual dysfunction.
Dickson RA; Glazer WM
J Clin Psychiatry; 1999 Feb; 60(2):125. PubMed ID: 10084644
[No Abstract] [Full Text] [Related]
17. A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia.
Costa AM; de Lima MS; Faria M; Filho SR; de Oliveira IR; de Jesus Mari J
J Psychopharmacol; 2007 Mar; 21(2):165-70. PubMed ID: 17329296
[TBL] [Abstract][Full Text] [Related]
18. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
Haefliger T; Bonsack C
Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
[TBL] [Abstract][Full Text] [Related]
19. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
[TBL] [Abstract][Full Text] [Related]
20. Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.
Yasui-Furukori N; Saito M; Nakagami T; Sugawara N; Sato Y; Tsuchimine S; Furukori H; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):537-40. PubMed ID: 20170699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
